Taconic Insights

Biopharmaceutical Trends and R&D

Taconic Biosciences has remained one of the world's leading providers of research models and services for over 60 years through our commitment to anticipating clients’ needs and industry trends. One of the key trends of the past ten years involves our clients’ need to strategically outsource functional areas of their R&D programs. When companies, academic institutions, government agencies and others outsource certain R&D functions they begin to rely on their collaborators, such as Taconic, to keep them apprised of emerging science and technologies in our specific areas of expertise.
In this spirit of collaboration, we present "Taconic Insights", a new section of our website dedicated to educating the industry on key scientific and technological trends impacting biopharmaceutical R&D. Here you will find the latest insights Taconic can provide in the form of articles, white papers, videos, webinars, presentations, and other media.

Proposed Changes to ICH Carcinogenicity Testing Guidelines — Decision Delayed

While evidence mounts in support of revised carcinogenicity testing guidelines, the number of Carcinogenicity Assessment Documents (CAD) submitted to the ICH S-1 expert working group fell below expected levels. After extending the submission period by two years9, the expert working group (EWG) will meet in June of 2017 to review the conclusions of drug regulatory agencies on the viability of excluding some pharmaceutical agents from the requirement...

Read More

Modeling NK Cells in Immuno-Oncology

What do Rituximab, Trastuzumab, and numerous other cancer immunotherapies have in common? Their anti-tumor efficacy involves the potent tumor-killing activity of natural killer (NK) cells. The induction of antibody-dependent cellular cytotoxicity (ADCC) in NK cells forms the basis for many important ongoing clinical efforts. These efforts are being aided by humanized immune system (HIS) rodent models, which offer an improved in vivo system for translating therapies to...

Read More

Resuscitation Fluid Composition May Improve Sepsis Outcomes

While modern medicine has done little to improve the mortality rates from severe sepsis, modifications in resuscitation fluid composition may prevent disease progression and improve outcomes. Researchers at McMaster University recently demonstrated that altering the concentrations of gluconate and acetate in resuscitation fluid impacts both hepatic cytokine production and leukocyte recruitment in a C57BL/6 mouse model of sepsis. "Resuscitation fluid composition affects hepatic inflammation in a murine...

Read More

It's Time for Lyme Disease

Lyme Disease Bacteria, Borrelia burgdorferi2 It's easy to get excited about mild weather and the opportunity to relieve cabin fever by enjoying the great outdoors. I was not immune to the urge on February 24, 2017, when we had a record warm temperature of 73°F. I spent the day working in the yard cleaning up the winter debris. After a long day of work, I was in...

Read More

Rodent Alzheimer's Disease Model Supports New Therapies

In late 2016 Biogen reported exciting results for aducanumab, their Phase 1 monoclonal antibody therapy for Alzheimer's disease (AD). Patients who received aducanumab showed significant and dose-dependent reduction of brain Amyloid-β (Aβ) and slowing of disease progression. Pre-clinical studies in the APPSWE/Tg2576 mouse model of AD provided the mechanistic clues, dosing insights, and efficacy data that informed the design of Biogen's successful aducanumab Phase I trial. Now,...

Read More

Interested in Learning How the Microbiome Impacts Drug Discovery?

Attend the Translational Microbiome Conference in Boston this April to learn how the microbiome is impacting the drug discovery industry. This industry-leading, three-day conference "focuses on the potential for translational interventions in microbiome research and the challenges the industry will need to address to make this space successful." Taconic Biosciences — the only commercial provider of germ-free mice — will sponsor, speak, and conduct a workshop at...

Read More

Microbiome Research Symposia Review: Microbiome and Disease

Adapted from an image by Nathan Schmidt, University of Louisville Taconic Biosciences recently organized two research symposia on the microbiome and disease, with a focus on translational research. Attendees from across pharma, biotech, and academia convened for two days of presentations and discussions on the cutting edge in microbiome science. Advancing Microbiome Research Symposium: Microbiome & Disease, November 3, 2016, Potomac, MD The first symposium was held...

Read More

Colitis Animal Models in IBD Research Webinar Q&A

Dr. Philip Dubé recently presented a webinar on colitis animal models for IBD research. His presentation introduced three major types of colitis models — chemically-induced, genetically engineered spontaneous colitis models, and adoptive transfer models — with examples of specific models from each type reviewed. Due to time constraints, many of the questions submitted during the webinar went unanswered. We present a full Q&A here. Dextran Sulfate Sodium...

Read More

Are Gnotobiotic Isolators Always Necessary?

Housing system design is fundamentally linked to the stability and characteristics of the mouse microbiome - but are gnotobiotic isolators always necessary to prevent compositional changes in microbiota? A new study published by Randi Lundberg, DVM and co-authors from University of Copenhagen and Technical University of Denmark, characterized the gut microbiota of mice housed in individually ventilated cages (IVCs) and compared it to that of mice housed...

Read More

Oh Transgene, Where Art Thou?
Mapping Transgene Insertion

Over the last three decades, transgenic mice have become a critical in vivo modeling tool in biomedical research. Transgenic technique1, whereby an exogenous gene is inserted into the mouse genome by direct injection of DNA into the pronuclei of a zygote, has enabled thousands of new transgenic lines to be created2. However the technique is not without limitations. One of the biggest drawbacks of using pronuclear injection...

Read More